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Spectrin superfamilyDystrophin (DYS) is a ﬁlamentous protein that connects the cytoskeleton and the extracellular matrix via the
sarcolemma, conferring resistance to muscular cells. In this study, interactions between the DYS R16–21
fragment and lipids were examined using Langmuir ﬁlms made of anionic and zwitterionic lipids. The ﬁlm
ﬂuidity was modiﬁed by the addition of 15% cholesterol. Whatever the lipid mixture examined, at low surface
pressure (20 mN/m) few differences appeared on the protein insertion and the presence of cholesterol did not
affect the protein/lipid interactions. At high surface pressure (30 mN/m), the protein insertion was very low
and occurred only in zwitterionic ﬁlms in the liquid-expanded phase. In anionic ﬁlms, electrostatic interactions
prevented the protein insertion outright, and caused accumulation of the protein on the hydrophilic part of
the monolayer. Addition of cholesterol to both lipid mixtures drastically modiﬁed the protein–lipid interactions:
the DYS R16–21 insertion increased and its organization in the monolayer appeared to be more homogeneous.
The presence of accessible cholesterol recognition amino-acid consensus sequences in this fragment may
enhance the protein/membrane binding at physiological lateral pressure. These results suggest that the
anchorage of dystrophin to the membrane in vivo may be stabilized by cholesterol-rich nano-domains in the
inner leaﬂet of sarcolemma.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Dystrophin (DYS) is a long ﬁlamentous muscular protein of 427
kDa (about 175 nm long) [1,2]. Most of this length is due to a long
central rod domain composed of 24 spectrin-like repeats (R1 to
R24) folded into a triple-α-helical bundle [3]. The biological func-
tion of dystrophin is to protect the membrane against stress during
elongation/contraction muscular cycles. Its absence leads to the se-
vere disease Duchenne muscular dystrophy (DMD), whereas the
milder Becker muscular dystrophy (BMD) may be observed when
truncated proteins are expressed [4]. Due to its high levels of
STRs, dystrophin is a member of the spectrin-like superfamily [5].
A relationship has been suggested between the structural organi-
zation of the repeat domains in these proteins and the membrane's
protection against shearing stresses [3]. This function may result
from a homogeneous protein distribution along the membrane
caused by protein/lipid interactions. Indeed, spectrin is known to
bind to the inner membrane leaﬂet due to interactions withUniversité de Rennes 1, Institut
nce.
).
ights reserved.phosphatidylserine [6–9]. Moreover the presence of 10–20% cho-
lesterol (CHOL) facilitates the insertion of spectrin into phosphati-
dylethanolamine/phosphatidylcholine monolayers that were
preformed at low surface pressure, i.e. from 8 to 11 mN/m [10].
Even during its liquid-expanded phase (LE), spectrin binding ca-
pacity depends on the ﬂuidity of the monolayer. Our previous stud-
ies showed that fragments of the dystrophin rod domain interact
with membrane system models through electrostatic and/or hy-
drophobic forces [11,12].
This study is focused on the interaction of the speciﬁc dystrophin
fragment made of repeats R16 to R21 and a membrane model. This
construct has several speciﬁc features that set it apart from other
dystrophin fragments. For instance, it contains a hinge (H3) between
the repeats R19 and R20 [13,14]. The presence of H3 inmicrodystrophin
improves the capacity for muscle degeneration prevention, while
deletion of this hinge leads to the BMD phenotype [15,16]. In addition,
DYS R16–21 is coded by exons 42 to 53, which includes the hot-spot
between exons 45 and 53 where about one third of BMD patients
have mutations [17]. The fragment also mediates speciﬁc protein inter-
actions, such as the anchoring of neuronal NO Synthase (nNOS) to the
sarcolemma through R16–R17 [18]. The mislocalisation of nNOS in the
membrane leads to a decrease of muscular strength in dystrophin-
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where the cysteine-rich domain is known to bind to β-dystroglycan (β-
DG) in a membrane protein complex [20] that is located in detergent-
resistantmembrane. Sarcolemmal CHOL depletion induces theweaken-
ing of force contractions through the redistribution of β-DG, and is
accompanied by a reduction of β-DG/dystrophin interactions in favor
of β-DG/caveolin-3 interactions [21]. All these studies showed that
structural or lipid environmental modiﬁcations impact muscular
activity. Nevertheless, up to now little was known about the ability of
DYS R16–21 to interact with lipid membranes.
Here, we address the question of the DYS R16–21 anchorage in
mixed lipid ﬁlms and more particularly of the effect of CHOL on
the interaction. Since phosphatidylserine is speciﬁcally abundant
in the inner leaﬂet of the sarcolemma membrane, the effect of the
polar head charge was tested using a simpliﬁed mixture composed
of anionic dioleoylphosphatidylserine (DOPS) and zwitterionic
dioleoylphosphatidylcholine (DOPC) lipids. Because we chose un-
saturated lipids, the monolayers are in the LE phase regardless of
the surface pressure. A mix of dipalmitoylphosphatidylcholine
(DPPC) and DOPC was used to mimic a detergent-resistant mem-
brane as described [22,23]. Indeed DPPC has been reported to
form liquid-condensed (LC) phase domains and also to create sep-
arated phases when mixed with DOPC [24]. Cholesterol, also pres-
ent in the inner leaﬂet up to 25% [25], is known to modulate
membrane ﬂuidity, and particularly at high surface pressure, it
acts as a head group spacer because of its molecular orientation
in the monolayer. Moreover, CHOL is located mainly in the con-
densed phase formed by DPPC [26,27]. Langmuir monolayers
were used, which allowed for control of charge densities, of ﬂuidi-
ty, and of lipid packing according to speciﬁc lipid compositions and
surface pressures. Protein–lipid interactions and protein structure
were determined by combining tensiometric and ellipsometric
measurements with atomic force microscopy imaging. We evaluat-
ed the inﬂuence of 15% CHOL on the interaction of DYS R16–21 with
DOPC/DOPS and DOPC/DPPC lipid mixtures. Using two initial sur-
face pressures, two different lipid packings were tested. The
highest of these (30 mN/m) is considered to be comparable to
physiological membrane pressure [28,29].
Our results show that DYS R16–21 interacts with the lipid monolay-
er no matter what mixture was used, while the surface pressure has a
notable impact on the insertion. In addition, under high surface pressure
CHOL was shown to stabilize the fragment at lipid interface, likely
through the presence of two cholesterol recognition amino-acid con-
sensus (CRAC) sequences on the protein surface [30]. The presence of
CRAC sequences all along dystrophin allows speciﬁc protein/lipid inter-
actions that result in homogeneous protein distribution along themem-
brane. This anchorage could be related to lateral force transmission
during muscle elongation/contraction.
2. Experimental sections
2.1. Materials
All lipids were purchased from Avanti Polar Lipids (Alabama, US).
The pGEX-4T-1 plasmid vector and GSTrap HP and Sephacryl S-100 col-
umnswere bought fromGEHealthcare. BL21bacteria and restriction en-
zymes were purchased from Ozyme (St.-Quentin-en-Yvelines, France).
Puriﬁed bovine thrombin came from Stago (Asnières-sur-Seine, France).
2.2. Preparation of recombinant DYS R16–21 protein
The DYS R16–21 fragment begins at residue Ser 1994 and ends
with Thr 2686, using the full-length human dystrophin annotation
(NCBI NP_003997). In order to improve stability and as previously done
for other dystrophin fragments [31,32], we included a three-amino-acid
extension in the N-terminus and a seven-amino-acid extension in theC-terminus. The protein was cloned in pGEX-4T-1 then expressed in a
protease-deﬁcient Escherichia coli BL21 strain as a GST-tagged protein
[33]. Cell lysis was obtained by sonication after lysozyme treatment.
DYS R16–21 was further puriﬁed using GST afﬁnity chromatography.
After thrombin proteolysis (50 UI for 2 h at room temperature), the chro-
matography fractions were separated by salting-out with ammonium
sulfate. The target protein was collected at 24% salt saturation and
rediluted in TNE buffer (20 mM Tris, 150 mM NaCl, 0.1 mM EDTA,
pH 7.5). Puriﬁcation was achieved with size-exclusion chromatography
by passing it through a Sephacryl S-100 column (L 2.6 cm × H 60 cm)
at 1 mL/min using the same buffer. After puriﬁcation, the protein was
concentrated using a 30 kDa cut-off centrifugal concentrator. Purity
was assessed by 10% SDS-Polyacrylamide gel electrophoresis (SDS-
PAGE), and concentration was determined using a bicinchoninic acid
assay with a standard of serum albumin.
Circular dichroism spectra were acquired between 250 nm and
200 nm, with 1.5 μM of protein in TNE buffer at 20 °C (J-815, Jobin-
Yvon) using 0.2 cm path-length cells. The α-helical content was calcu-
lated from the mean molar residue ellipticity [θ] (mdeg.cm2.dmol−1)
at 222 nm [34].
2.3. Tensiometric and ellipsometric measurements
In order to investigate the interfacial properties of the protein with
and without lipids, surface pressure and ellipsometric angles were
measured in Teﬂon troughs (4, 8, or 60mL) at 20 °C. TheWilhelmymeth-
odwas used to determine the surface pressure using a tensiometer (Nima
Technology, Cambridge, UK). Ellipsometric measurements were
performed with a conventional polarizer–analyzer null-ellipsometer
setup. Brieﬂy, a He–Ne laser (632.8 nm; Melles Griot, Carlsbad, CA) with
an angle of incidence of 52.18° (1° away from the Brewster's angle),
was used as the light source. Reﬂecting surface properties were explored
by recording the positions of the polarizer and analyzer having the mini-
mal intensity of transmitted light. The analyzer anglewas doubled to yield
the value of the ellipsometric angle (Δ) [35–37]. Both Δ and the surface
pressure (π) were recorded as functions of time. The amphiphilic charac-
ter was determined by reporting the surface pressure reached at this end
of the absorption kinetics as a function of the protein's subphase concen-
trations (ranging from0.0001 μMto 1 μM). For lipid/protein experiments,
the lipidmixtures (DOPC/DOPS1:1molar ratio andDOPC/DPPC 1:1molar
ratio) were prepared in a 2:1 chloroform/methanol solution (v/v) at
0.5mM, andwhere used, CHOLwas added at 15% (molar ratio). The lipids
were gently spread at the air/liquid interface of the TNE subphase at the
desired surface pressure. These initial lipid surface pressures (πi) ranged
from 5 to 35 mN/m. At a ﬁnal concentration of 0.03 μM, the protein was
then injected into the subphase just beneath the lipidmonolayer. The var-
iations (δΔ and Δπ) induced by protein adsorption at the end of the ab-
sorption kinetics were reported as functions of time and πi. Each
experiment was repeated up to four times and means ± standard devia-
tion (SD)were provided for each series. The temperature varied between
19 and 21 °C.
2.4. Atomic force microscopy (AFM) observations
The interfacial ﬁlm was transferred onto a freshly-cleaved mica plate
using the Langmuir–Blodgett technique. The experiment was realized
using a 102 cm2 Langmuir trough equipped with two movable barriers
and controlled by a computer (model 601 M, Nima Technology,
Cambridge, UK). The transfer was performed at the end of the kinetics
and at a constant surface pressure. The dipper speed rate was 1 mm/
min. Transferred monolayers were imaged using a PicoPlus atomic force
microscope (Agilent Technologies, Phoenix, AZ) equipped with a 10 μm
scanner operating in contact mode. Images were acquired under
ambient conditions using silicon nitride tips on integral cantilevers
(ScienTec) with a spring constant of 0.06 N/m. For each measurement,
the set point was adjusted before and during the scanning to minimize
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obtained from at least two samples prepared on different days, with
at least four macroscopically-separated areas in each sample. To deter-
mine the height of the objects, after processing the images with
Gwyddion 2.26 software (http://gwyddion.net) we did a statistical analy-
sis. Objects of interest were selected by threshold, and then areas and
maximal heights were determined. The values of height versus area
were plotted, resulting in a plateau. This plateau included the
majority of the objects andwas used to compare the different experimen-
tal conditions.
2.5. Three-dimensional molecular homology modeling and surface
properties
Three-dimensional (3D) homology models were obtained using
I-TASSER server [38]. As previously described [39], the sequences
of two successive repeats (“tandem repeats”) with an overlap of a
single repeat were submitted to I-TASSER (e.g. DYS R16-17, then
DYS R17–18, and so on). The H3 sequence was submitted separate-
ly. Superposition of the shared repeat of two successive tandem re-
peats allowed the construction of an extended model which we
further minimized by YASARA (e.g. the DYS R16–17 and DYS
R17–18 models were used to construct a DYS R16–18 model). In
this way, step by step, the global 3D structure was reconstructed.
Surface hydrophobicity was calculated using PLATINUM [40] and
surface electrostatic potentials in the presence of 50 mM NaCl
were calculated using the Adaptive Poisson–Boltzmann Solver
(APBS) software [41]. Visualization was done using VMD and
PyMOL.
3. Results
3.1. Protein puriﬁcation
SDS-PAGE of the recombinant human dystrophin fragment DYS
R16–21 (Fig. 1A) showed the protein at the expected molecular
weight of 80 kDa. As expected with spectrin-like repeats [11,42],
the circular dichroism spectrum of DYS R16–21 displayed the typ-
ical predominant α-helix folding with two minima at 208 and
222 nm (Fig. 1B). Per Chen et al., the molar ellipticity of 222 nm
allowed for determination of an α-helix content of 83% [43]. The
ratio of the molar ellipticity at 222 and 208 nm (θ222/θ208) was
1.05, indicating that the helices were interacting and folded in a
coiled-coil [44]. Therefore, it appears that the recombinant DYS
R16–21 fragment was highly puriﬁed and correctly folded, condi-
tions necessary for its further study.Wavelength (nm)
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Fig. 1. DYS R16–21 sub-domain puriﬁcation and secondary structure analysis. (left) 10%
SDS polyacrylamide gel of DYS R16–21 obtained after puriﬁcation. Lane M is the protein
ladder. (right) Circular dichroism measurements of 1.5 μM of DYS R16–21 in TNE buffer
(pH 7.5) at 20 °C.3.2. Amphiphilic properties of DYS R16–21
For each DYS R16–21 subphase concentration between 0.0001 and 1
μM, surface pressure measurements were done and the ﬁnal surface
pressure versus subphase protein concentrations are reported in
Fig. 2A. As the protein concentration increased, π increased until a
plateau (πmax) of 21 mN/m was reached, indicating the amphiphilic
character of DYS R16–21. From these adsorption kinetic results, the crit-
ical concentration required for interface saturation was determined to
be 0.1 μM. For further experiments, a protein concentration of 0.03 μM
(or 2.5 μg/mL) was chosen (indicated with an arrow in Fig. 2A) to
avoid a potential aggregation of proteins in the subphase or the forma-
tion of multilayers at the interface. Fig. 2B shows a typical adsorption
time for this protein concentration. Whereas surface pressure is related
to the protein's ability to cover the interface and to interact laterally, the
ellipsometric angle depends on the amount ofmatter at the interface. As
is usual, at the very beginning of the adsorption the ellipsometric angle
increased quicker than the surface pressure. It reached an angle of 10° at
equilibrium, a value corresponding to a monolayer as experienced in
other proteins [45]. AFM imagery of this monolayer at the end of the
adsorption kinetics (Fig. 2C) showed a homogeneous ﬁlm with no
aggregation.
3.3. DYS R16–21 interaction with lipid monolayers
The adsorption kinetics of DYS R16–21 was monitored at various
initial lipid surface pressures (πi). The variations of the surface pressure
(Δπ) i.e. the difference between the initial lipid surface pressure and the
ﬁnal surface pressure were reported as a function of πi (Fig. 3). When πi
increased, Δπ induced by adsorption of DYS R16–21 decreased. Indeed
as the lipids compacted, the proteinwas less and less able to be inserted
into the lipid monolayer. When there was no more variation between
the initial and ﬁnal surface pressures (Δπ= 0 or intercept of the linear
regression with the x axis as indicated with arrows in Fig. 3), the maxi-
mal insertion pressure (MIP) was reached [46]. This was clearly depen-
dent on the lipidmixture, with values of 26.5mN/m for DOPC/DOPS and
33 mN/m for DOPC/DPPC.
For πi less than 20 mN/m, Δπ was higher with anionic than with
zwitterionic lipids, suggesting an attractive role for electrostatic inter-
actions in the insertion of DYS R16–21. On the other hand, when πi
was higher than 20 mN/m, Δπwas higher with zwitterionic lipids, sug-
gesting presence of hydrophobic interactions during the protein's inser-
tion process, while electrostatic interactions limit the insertion.
Moreover, for the DOPC/DOPS monolayer at an initial surface pressure
higher than πe (26 mN/m), the protein induced a surface pressure
decrease (Δπ=−1.6 mN/m), thus showing that attractive interactions
were still taking place between DYS R16–21 and the compacted DOPC/
DOPS monolayer.
To further analyze the organization of DYS R16–21 in lipid environ-
ments, we focused our work on lipid monolayers formed at two signif-
icant initial surface pressures: 20 mN/m, where the protein adsorption
induced similar overpressures for all lipid compositions tested; and
30 mN/m, considered to be close to physiological membrane pressure
[29]. All reported values are recapitulated in Table S1.
3.4. Cholesterol has few effects at a πi of 20 mN/m
Cholesterol is known to inﬂuence lipid packing therefore we studied
the impact of 15% CHOL on the DYS R16–21/lipid interactions. At πi of
20 mN/m (Fig. 4A), no changes were observed upon the addition of
CHOL to the DOPC/DOPS ﬁlm, while there was a slight increase of Δπ
and δΔ (1 mN/m and 0.4° respectively) in the DOPC/DPPC mixture.
AFM images of pure lipid ﬁlms were unmodiﬁed in the presence of
CHOL. DOPC/DOPS ± CHOL (Fig. 4B) formed a homogeneous liquid-
expanded (LE) phase. DOPC/DPPC ± CHOL images (Fig. 4E) showed
the coexistence of an LE phase of DOPC and a liquid-condensed (LC)
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Fig. 2. DYS R16–21 adsorption at the air–liquid interface. (A) Final surface pressure reached at the end of the adsorption kinetics versus DYS R16–21 subphase concentrations. Arrow
indicatesπ reached for protein subphase concentration of 0.03 μM(B)Adsorption kinetics of DYS R16–21 at air–liquid interface for the subphase concentration of 0.03 μM, surface pressure
(+), and ellipsometric angle (o). (C) AFM topographic image of transferredDYS R16–21monolayer at the end of the kinetics (5 h). Surface pressurewas 20 mN/m. Scan size 5 μm×5 μm, z
scale 10 Å.
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several μm in diameter and their apparent height was 1.4 ± 0.1 nm.
Mixed protein/lipid ﬁlms showed bright protrusions attributed to
the protein's presence (Fig. 4C–H). In DOPC/DOPS ± CHOL ﬁlms, these
protrusions appeared mostly as worm-like curved ﬁlaments (Fig. 4C–
D). CHOL induced both protein clustering and an increase in the appar-
ent height of protrusions (2.1 ± 0.1 nm without CHOL versus 2.7 ±
0.1 nm with CHOL). These changes in DYS R16–21 organization oc-
curred even though the lateral pressure and the amount of material at
the interface were similar with or without CHOL (Fig. 4A).
In DOPC/DPPC ﬁlms (Fig. 4E–H), the presence of DYS R16–21 drasti-
cally decreased the LC domain's diameter, which never exceeded
400 nm.Without CHOL (Fig. 4 F–G), the proteins appeared as round ob-
jects or ﬁlaments with heights higher (2.0 ± 0.1 nm) than those of LC
domains (1.4 ± 0.1 nm). The ﬁlaments were most often stuck to an LC
phase (detailed view, Fig. 4G) whereas round objects were located in
an LE phase. In the presence of CHOL (Fig. 4H), higher ﬁlaments (3.1
± 0.2 nm) were located both in the LE phase and at the boundaries of
LE/LC phases.
3.5. Cholesterol increases DYS R16–21 insertion at a πi of 30 mN/m
Ellipsometric and tensiometric measurements (Fig. 5A) showed that
in any lipid condition, a πi of 30 mN/m induced the presence of less
protein at the interface than with a πi of 20 mN/m. Injection of DYS
R16–21 under the DOPC/DOPS/CHOL monolayer led to an increase in
surface pressure (from−1.6 mN/m without CHOL to +2 mN/m with
CHOL) and a decrease in the ellipsometric angle (from 0.6° without
CHOL to 0.2° with CHOL), indicating modiﬁed protein/lipid interactions-2
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Fig. 3.Overpressure induced by adsorption of DYS R16–21 at air/lipid interface versus the
initial lipid surface pressures of DOPC/DOPS (full line) and DOPC/DPPC (dotted line).
Arrows indicate thevalues ofmaximal insertion pressures (MIP). The subphase concentra-
tion of DYS R16–21 was 0.03 μM.that favor the insertion of DYS R16–21. In the DOPC/DPPC ﬁlms, the
presence of CHOL had no signiﬁcant effects on ellipsometric angle vari-
ation after injection of DYS R16–21, whereas the presence of CHOL
induced an increase in Δπ (from 0.3 mN/m without CHOL to 2 mN/m).
The AFM images of DOPC/DOPS ﬁlmswith or without CHOL (Fig. 5B)
were similar to those at 20 mN/m. The DOPC/DPPC/CHOL AFM images
revealed that the presence of CHOL caused a slight decrease in height
of LC domains (from 1.4 nm without CHOL to 1.2 nm) (Fig. 5E).
In the DOPC/DOPS/protein ﬁlms (Fig. 5C), DYS R16–21 appeared as
protrusions forming heterogeneous clusters higher (3.6 ± 0.4 nm)
and larger than those previously observed at a πi of 20 mN/m. This is
consistent with the variations in surface pressures and ellipsometric
angles seen with the two surface pressures (Figs. 4A and 5A). In the
presence of CHOL (Fig. 5D), the proteins formed small protrusions that
are smaller in length, width, and height (2.3 nm ±0.1) than those in
the absence of CHOL or with a smaller πi. Finally, the protein organiza-
tion was more homogeneous, with deeper insertion into the lipid
monolayer and less material at the interface.
In DOPC/DPPC/protein ﬁlms (Fig. 5F), the protein was present as
scarce clusters in agreement with the low Δπ. Their heights (between
1 and 4 nm), were very heterogeneous. By contrast, CHOL induced
numerous clusters of DYS R16–21 (Fig. 5G–H) with heights of 2.6 ±
0.2 nm. The LC domain borders were much more irregular and angular
than without CHOL. The protein clusters appear to be more elongated
when in contact with LC domains than when embedded in LE domains
(detailed view, Fig. 5H). Some objects also appeared to be embedded in
LCdomains, but since therewas a depression surrounding these clusters
it was obvious that there was no direct contact between the LC and the
protein.
3.6. Computational analysis of DYS R16–21in presence of 50 mM NaCl
As expected for a soluble protein, themolecular surface of DYS R16–
21 is mainly hydrophilic. Nevertheless one side of the fragment displays
a higher presence of hydrophobic amino acids (Fig. 6). The electrostatic
potential at the molecular surface shows a distribution of negative and
positive charges along the molecule. Numerous positive patches were
observed, mainly on repeats 16 and 17 of DYS R16–21, with the rest
dispersed more widely along the molecule and embedded in the nega-
tive surface. A rotated view of the fragment showed a more contrasted
surface with larger negative patches, separated by a few small positive
zones that appear mostly on repeats 18 and 19. Interestingly, some
hydrophobic patches colocalize or are very close to the cationic surface
(for example on R16, R18 and R20). Thesemay thus be anchorage points
for interaction or insertion in anionic and zwitterionic lipid monolayers
even under high initial surface pressures.
A search of the primary sequence of dystrophin revealed several
occurrences of the CRAC pattern –(L/V)–(X)1–5–Y–(X)1–5–(R/K)– [30].
Due to this sequence, a cholesterol binding cleft is created where Y
Fig. 4. Characterization of DYS R16–21 at the initial lipid surface pressure of 20 mN/m.
(A) Variations of the surface pressure (Δπ) and of the ellipsometric angle (δΔ) induced
by DYS R16–21 adsorption on phospholipid monolayers (black) and phospholipid/CHOL
monolayers (gray). (B–H) Typical AFM topographic images of monolayers as indicated
on the panels. Scan size 5 μm × 5 μm for images B–F and H, and 2 μm × 2 μm for image
G. Z-range 80 Å. When present, DYS R16–21 subphase concentration is 0.03 μM, CHOL
15%. LE, liquid-expanded phase; LC, liquid-condensed phase.
Fig. 5. Characterization of DYS R16–21at an initial lipid surface pressure of 30 mN/m.
(A) Variations of the surface pressure (Δπ) and of the ellipsometric angle (δΔ) induced
by DYS R16–21 absorption on phospholipid (black) and phospholipids/CHOLmonolayers
(gray). (B–H) Typical AFM topographic images of monolayers as indicated on the panels.
Scan size 5 μm × 5 μm for images B–G and 2 μm × 2 μm for image H. Z-range 80 Å.
When present, DYS R16–21 subphase concentration is 0.03 μM and CHOL, 15%. LE,
liquid-expanded phase; LC, liquid-condensed phase.
1270 S. Ameziane-Le Hir et al. / Biochimica et Biophysica Acta 1838 (2014) 1266–1273and R/K interact directly with CHOL [48]. In DYS R16–21, the pattern
was found in the C helix of R16 (V2088NKMYKDR2098) and in the R21
B–C loop (L2647RDYSADDTR2657) (Fig. 6). Most of the amino acids in-
volved are exposed on the surface, and accessible enough to enable
interaction with CHOL molecules.
4. Discussion
In this study, we examine the interaction of DYS R16–21 with lipid
monolayers. This particular dystrophin fragment is characterized by
the presence of hinge 3 (H3) and is frequently mutated in patients.
DYS R16–21 displayed amphiphilic properties that were probably dueto the presence of hydrophobic amino-acids all along the surface
(Fig. 6). Compared with previously-studied rod domain fragments, the
adsorption of DYS R16–21 at the air/water interface was faster, the pla-
teau was reached at a smaller protein concentration but has a similar
value of 21 mN/m [12,49]. This indicates both that the interface is
more rapidly covered by the protein, and that the molecules do indeed
interact with each other. This result could be related to the larger size of
the protein as compared to other dystrophin fragments previously stud-
ied, and/or to the presence of H3, which may make the protein's struc-
ture more ﬂexible [13].
The monolayer's initial lipid surface pressure (πi) is a major factor
inﬂuencing the adsorption of amphiphilic proteins through electrostatic
or hydrophobic forces because it determines lipid packing.When πi was
Fig. 6.Molecularmodeling of DYS R16–21. The 3D structure of DYS R16–21was created in I-TASSER. The hydrophobic potential at themolecular surface (top row) is colored by increasing
hydrophobicity from green (polar) to yellow (hydrophobic). The electrostatic potential at themolecular surface (middle row) is colored by increasing levels from red (−) to blue (+). The
N-terminus (R16) is located at the left of the molecules. Left and right images in the top rows are representations of a 180°-rotation along the molecule's long axis. Bottom row: 3D
structure of DYS R16–21 in cartoon representation. Each dystrophin repeat is a different gray. Amino acids of the CRAC (cholesterol recognition/interaction amino acid consensus) patterns
are red.
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and zwitterionic monolayers; however the maximal insertion pressure
was signiﬁcantly lower for the anionicmixture suggesting that attractive
electrostatic interaction plays a major role in DYS R16–21–membrane
interactions. The negative charge of the polar head attracts the protein
toward the membrane, allowing further hydrophobic interactions to
occur thanks to free interfacial space. At a πi of 20 mN/m, the protein in-
sertion overpressures and ellipsometric angle variations seem to be
equivalent for both lipid mixes. AFM observations show the protein as
round or ﬁbrous objects with regular heights (about one protein
thick). The ﬁbrous objects were present in the anionic mix, and inter-
connected ﬁlaments were only detected in contact with LC domains.
These features imply that the molecules were stabilized at the interface
by negative charges or LC domains and then adopted the same orienta-
tion at the lipid interface. This favors the existence of lateral protein/
protein interactions in both lipid mixtures. At a πi over 20 mN/m, elec-
trostatic interactions still occur but the space between lipid head groups
becomes more and more limited, and the fragment insertion slows. Fi-
nally, when the πi of the DOPC/DOPS ﬁlm was over 26 mN/m, interac-
tions with lipid head groups caused a reorientation and relaxation of
the ﬁlms, as shown by a decrease in the ﬁnal surface pressure, and the
protein appears as irregular clusters. This phenomenon has been report-
ed previously for the dystrophin R2 repeat [50], DYS R20–24 [12] and in
α-spectrin [6]. In zwitterionic ﬁlm, however, the insertion of DYS R16–
21 occurs up to 31 mN/m. This is probably because the protein's orien-
tation is not driven by electrostatic interactions and because its ﬂexibil-
ity allows for penetration of the ﬁlms even at higher surface pressures.
When comparing the anionic monolayer insertion of the previously-
studied fragments DYS R1–3, DYSR11–15 andDYSR20–24 to that of the
DYS R16–21 studied here, different behaviors are seen, thus demon-
strating that these fragments are not interchangeable as had been stated
[51]. Indeed, at 30 mN/m, only DYS R11–15 inserts into the monolayer
(Δπ=+2 mN/m) [49], whereas both DYS R16–21 and R20–24 stayed
at the head group level [12].
At 20 mN/m, a gradient seems to occur along the central domain,
with greater insertion for fragments from the N- to C-terminal ends
(Δπ= 7 mN/m for DYS R1–3, 6 mN/m for DYS R11–15, and 5 mN/m
for DYS R16–21 and DYS R20–24). This intriguing observation must be
further studied to decipher whether it has a physiological signiﬁcance.
It would be especially interesting to understand the relationship
between the variation in sarcolemmal lateral pressure during muscle
elongation/contraction, and the number or position of anchoring points
along the protein. Interestingly, it has been reported that binding of
spectrin to phosphatidylserine in the inner membrane increases the
mechanical stability of red blood cell membranes [52].We examined dystrophin/lipid/CHOL interactions because of
cholesterol presence in the membrane and of its impact on the
membrane's physical properties. Moreover we report the existence
of a speciﬁc amino-acid sequence called CRAC (cholesterol recog-
nition amino-acid consensus) and involved in CHOL binding
[30,53]. Like spectrin [54,55], dystrophin has been shown to be as-
sociated in vivo to detergent-resistant membranes [56] and the in-
teraction between β-DG and dystrophin is weakened by CHOL
depletion [21]. The impact of CHOL on the structural and lateral or-
ganization of lipid layers is highly-documented [27,57,58], in par-
ticular its role as head group spacer and its usual localization in
the condensed phase formed by DPPC [26]. In addition, several
monolayer experiments have shown complex formation between
CHOL and phosphatidylserine, an important component of the
inner leaﬂet [59]. Our study was performed at 15% of CHOL since
10 to 20% CHOL have been shown to increase spectrin insertion in
phosphatidylethanolamine/phosphatidylcholine monolayers [10]
and also because this concentration is known to preserve lateral
phase separation [60]. At the lower initial surface pressure
(20 mN/m), macroscopic measurements (π, Δ) were unmodiﬁed
in presence of CHOL, but topographic images revealed an increase
in the lateral size and height of protein protrusions, indicating
changes in the molecular organization of DYS R16–21 within the
lipid monolayers. CHOL favors lateral protein–protein interactions,
and since the lipids are in ﬂuid phase, it increases steric packing in
the hydrophobic part, limiting deep anchoring. In the DOPC/DPPC
mixture, LC domain fragmentation is induced by the protein. DYS
R16–21 insertion might induce local disorders in the lateral pack-
ing of the acyl chains. These hydrophobic mismatch defects result
in lateral fragmentation of these domains, and this phenomenon
is ampliﬁed by the presence of CHOL[61,62]. At a higher initial sur-
face pressure (πi = 30 mN/m), CHOL ampliﬁes protein insertion
into lipid monolayers and favors a homogeneous organization of
the protein in both LC and LE domains. Indeed, the sterol polar
head group is small compared to choline or serine, while the hy-
drophobic part at this pressure is similar to that of a
phosphatidylcholine-saturated chain [24], thus CHOL plays the
role of head group spacer. This promotes a deeper and more ho-
mogenous lipid insertion. The DOPS/DYS R16–21 electrostatic in-
teractions are modiﬁed by CHOL. This could be linked either to
PS/CHOL complex formation as suggested by Radhakrishnan et al.
[59] or to speciﬁc DYS R16–21/CHOL interactions.
Bio-informatics analysis of the DYS R16–21 amino acid sequence re-
vealed two occurrences of the CRAC sequence –(L/V)–(X)1–5–Y–
(X)1–5–(R/K)– [30]. CRAC sequences are also present in spectrin and
1272 S. Ameziane-Le Hir et al. / Biochimica et Biophysica Acta 1838 (2014) 1266–1273in other dystrophin fragments (Table S2). These patterns in DYS R16–21
are easily accessible for interaction at the protein surface. Not only has
CRAC been identiﬁed in many proteins that interact with
cholesterol, but it has been more widely suggested to be related to
protein propensity for interaction with cholesterol-rich lipid domains
[63]. CRAC motifs are often reported in membrane proteins, but are
compatible with peripheral proteins andwere also reported in a secret-
ed toxin [64].
5. Conclusion
Our results highlight the fact that dystrophin fragments, and here
especially DYS R16–21, can interact directly with monolayers at high
surface pressure, at low ﬂuidity, and in the presence of anionic lipids.
We further show that thepresence of dystrophin close to themembrane
is probably not due only to a link with β-DG but also thanks to its own
sub-part membrane-binding properties. It has now to be tested
whether our in vitro results may be transposed in vivo. Does formation
of direct interactions between dystrophin and cholesterol-rich nano-
domains stabilize the dystrophin/β-DG/sarcolemma in muscular cells?
If so, cholesterol-rich domains in the inner sarcolemma layer could
prevent ejection of dystrophin under surface pressure variations
due to contraction/elongation cycles and contribute to sarcolemma
resistance.
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